Apitherapy applied to the treatment of onychomycosis: a critical review of the literature on propolis
DOI:
https://doi.org/10.33448/rsd-v11i13.35312Keywords:
Onychomycosis; Antifungal Agents; Propolis; Dermatophytes; Apitherapy.Abstract
Onychomycosis is a nail infection caused by fungi, affects about 5.5% of the world population, and is more frequent in individuals over 60. The agents of infection are dermatophyte fungi (60% to 70%), non-dermatophyte filamentous fungi and yeast (together they add up to 30% to 40%). Treatment includes topical or oral antifungal drugs, and treatment time ranges from three months to more than a year. Alternative therapies are used empirically based on popular culture. The aim of this study was to review the literature on the use and effectiveness of propolis and its derivatives in the treatment of nail mycosis. For this, virtual libraries, search sites and databases were used: Scielo, Pubmed and Portal Periodicals of CAPES, including publications until February 2022. The search words (in Portuguese and in their respective versions in English) were: (“onychomycosis” OR “tinea unguium” OR “nail mycosis”) AND (“treatment” OR “therapy”) AND (“propolis”). Eight articles were included in this study, and the majority (five) evaluated the activity of propolis in vitro on fungal agents of nail mycosis, two studies simultaneously evaluated propolis in the treatment of onychomycosis in vivo, in vitro and ex vivo and one study analyzed the in vivo treatment. Thus, it was found that propolis has antifungal activity and can be considered as a complementary or alternative therapy for the treatment of onychomycosis.
References
Baswan, S., Kasting, G. B., Li, S. K., Wickett, R., Adams, B., Eurich, S., & Schamper, R. (2017). Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases. Mycoses, 60(5), 284–295. https://doi.org/10.1111/myc.12592
Brasil. (2006) Ministério da Saúde. Política Nacional de Práticas Integrativas e Complementares no SUS - PNPIC-SUS. Brasília.
Brasil. (2018) Ministério da Saúde. Glossário temático: práticas integrativas e complementares em saúde. Brasília.
Brasil. (2020) Ministério da Saúde. Práticas integrativas e complementares. Brasília. https://saude.gov.br/saude-de-a-z/praticas-integrativas-e-complementares, 19 de setembro de 2020.
Burdock, G. (1998). Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology, 36(4), 347–363.
Callejo, A., Armentia, A., Lombardero, M., & Asensio, T. (2001) Propolis, a new bee-related allergen. Allergy 56:579.
Cordeiro, A. M., Oliveira, G. M. D., Rentería, J. M., & Guimarães, C. A. (2007). Systematic review: a narrative review. Revista do Colégio Brasileiro de Cirurgiões. 34(6), 428-431.
Galletti, J., Tobaldini-Valerio, F. K., Silva, S., Kioshima, É. S., Trierveiler-Pereira, L., Bruschi, M., Negri, M., & Estivalet Svidzinski, T. I. (2017). Antibiofilm activity of propolis extract on Fusarium species from onychomycosis. Future microbiology, 12, 1311–1321. https://doi.org/10.2217/fmb-2017-0052
Groot A. C. (2013). Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis: contact, atopic, occupational, drug, 24(6), 263–282. https://doi.org/10.1097/DER.0000000000000011
Gupta, A., Daigle, D., & Foley, K. (2015). The prevalence of culture confirmed toenail onychomycosis in at-risk patient populations. Journal of the European Academy of Dermatology and Venereology, 29(6), 1039-1044.
Gupta, A. K., Versteeg, S. G., & Shear, N. H. (2017). Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment. Journal of cutaneous medicine and surgery, 21(6), 525–539. https://doi.org/10.1177/1203475417716362
Hausen, B. M., Wollenweber, E., Senff, H., & Post, B. (1987). Propolis allergy. (I). Origin, properties, usage and literature review. Contact dermatitis, 17(3), 163–170. https://doi.org/10.1111/j.1600-0536.1987.tb02699.x
Hausen, B. M., Evers, P., Stüwe, H. T., König, W. A., & Wollenweber, E. (1992). Propolis allergy (IV). Studies with further sensitizers from propolis and constituents common to propolis, poplar buds and balsam of Peru. Contact dermatitis, 26(1), 34–44. https://doi.org/10.1111/j.1600-0536.1992.tb00865.x
Khosravi, A. R., Shokri, H., Nikaein, D., Mansouri, P., Erfanmanesh, A., Chalangari, R., & Katalin, M. (2013). Yeasts as important agents of onychomycosis: in vitro activity of propolis against yeasts isolated from patients with nail infection. Journal of alternative and complementary medicine (New York, N.Y.), 19(1), 57–62. https://doi.org/10.1089/acm.2011.0722
Khurshid, Z., Naseem, M., Zafar, M. S., Najeeb, S., & Zohaib, S. (2017). Propolis: A natural biomaterial for dental and oral healthcare. Journal of dental research, dental clinics, dental prospects, 11(4), 265–274. https://doi.org/10.15171/joddd.2017.046
Koc, A. N., Silici, S., Ayangil, D., Ferahbaş, A., & Cankaya, S. (2005). Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Mycoses, 48(3), 205–210. https://doi.org/10.1111/j.1439-0507.2005.01128.x
Lipner, S. R., & Scher, R. K. (2019). Onychomycosis: Clinical overview and diagnosis. Journal of the American Academy of Dermatology, (80) 4, 835-851.
Longhini, R., Raksa, S. M., Oliveira, A. C. P., Svidzinski, T. I. E., & Franco, S. L. (2007). Obtenção de extratos de própolis sob diferentes condições e avaliação de sua atividade antifúngica. Revista Brasileira de Farmacognosia, 17(3), 388–395. https://doi.org/10.1590/s0102-695x2007000300015
Lustosa, S. R., Galindo, A. B., Nunes, L. C. C., Randau, K. P., & Rolim Neto, P. J. (2008). Própolis: atualizações sobre a química e a farmacologia. Revista Brasileira de Farmacognosia, 18(3), 447–454. https://doi.org/10.1590/s0102-695x2008000300020
Machado, C. S., Mokochinski, J. B., Lira, T. O. d., de Oliveira, F. d. C. E., Cardoso, M. V., Ferreira, R. G., Frankland Sawaya, A. C. H., Ferreira, A. G., Pessoa, C., Cuesta-Rubio, O., Monteiro, M. C., de Campos, M. S., & Torres, Y. R. (2016). Comparative Study of Chemical Composition and Biological Activity of Yellow, Green, Brown, and Red Brazilian Propolis. Evidence-Based Complementary and Alternative Medicine, 2016, 1–11. https://doi.org/10.1155/2016/6057650
Menniti-Ippolito, F., Mazzanti, G., Vitalone, A., Firenzuoli, F., & Santuccio, C. (2008). Surveillance of suspected adverse reactions to natural health products: the case of propolis. Drug safety, 31(5), 419–423. https://doi.org/10.2165/00002018-200831050-00007
Oliveira, A. C. P., Shinobu, C. S., Longhini, R., Franco, S. L., & Svidzinski, T. I. E. (2006). Antifungal activity of propolis extract against yeasts isolated from onychomycosis lesions. Memórias do Instituto Oswaldo Cruz, 101(5), 493–497. https://doi.org/10.1590/s0074-02762006000500002
Papini, M., Piraccini, B. M., Difonzo, E., & Brunoro, A. (2015). Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification. Mycoses, 58(11), 659–664. https://doi.org/10.1111/myc.12396
Park, Y. K., Ikegaki, M., & de Alencar, S.M. (2000). Classificação das própolis brasileira a partir de suas características físico-químicas e propriedades biológicas. Mensagem Doce, 58(1), 2–7.
Park, Y. K., Alencar, S. M., & Aguiar, C. L. (2002). Botanical origin and chemical composition of Brazilian propolis. Journal of agricultural and food chemistry, 50(9), 2502–2506. https://doi.org/10.1021/jf011432b
Pasupuleti, V. R., Sammugam, L., Ramesh, N., & Gan, S. H. (2017). Honey, Propolis, and Royal Jelly: A Comprehensive Review of Their Biological Actions and Health Benefits. Oxidative medicine and cellular longevity, 2017, 1259510. https://doi.org/10.1155/2017/1259510
Santos, L. M., Fonseca, M. S., Sokolonski, A. R., Deegan, K. R., Araújo, R. P., Umsza-Guez, M. A., Barbosa, J. D., Portela, R. D., & Machado, B. A. (2020). Propolis: types, composition, biological activities, and veterinary product patent prospecting. Journal of the science of food and agriculture, 100(4), 1369–1382. https://doi.org/10.1002/jsfa.10024
Tsentemeidou, A., Vyzantiadis, T. A., Kyriakou, A., Sotiriadis, D., & Patsatsi, A. (2017). Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study. Mycoses, 60(12), 830–835. https://doi.org/10.1111/myc.12681
Vasconcellos-Pontello, V., Veiga, F. F., Gadelha, M. C., Ribeiro, M., Negri, M., & Estivalet Svidzinski, T. I. (2021). The Success of Topical Treatment of Onychomycosis Seems to Be Influenced by Fungal Features. Evidence-based complementary and alternative medicine: eCAM, 2021, 5553634. https://doi.org/10.1155/2021/5553634
Veiga, F. F., Costa, M. I., Cótica, É., Svidzinski, T., & Negri, M. (2018a). Propolis for the Treatment of Onychomycosis. Indian journal of dermatology, 63(6), 515–517. https://doi.org/10.4103/ijd.IJD_365_17
Veiga, F. F., Gadelha, M. C., da Silva, M., Costa, M. I., Kischkel, B., de Castro-Hoshino, L. V., Sato, F., Baesso, M. L., Voidaleski, M. F., Vasconcellos-Pontello, V., Vicente, V. A., Bruschi, M. L., Negri, M., & Svidzinski, T. (2018b). Propolis Extract for Onychomycosis Topical Treatment: From Bench to Clinic. Frontiers in microbiology, 9, 779. https://doi.org/10.3389/fmicb.2018.00779
Velasquez-Agudelo, V., & Cardona-Arias, J. A. (2017). Meta-analysis of the utility of culture, biopsy, and direct KOH examination for the diagnosis of onychomycosis. BMC infectious diseases, 17(1), 166. https://doi.org/10.1186/s12879-017-2258-3
Zisova, L., Valtchev, V., Sotiriou, E., Gospodinov, D., & Mateev, G. (2012). Onychomycosis in patients with psoriasis--a multicentre study. Mycoses, 55(2), 143–147. https://doi.org/10.1111/j.1439-0507.2011.02053.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bruna Lima Perissato; Reginaldo dos Santos Pedroso
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
